Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
{{output}}
Background: A considerable number of people with multiple sclerosis (pwMS) live in low- and middle-income countries (LMIC), where lack of resource adversely affects access to effective disease-modifying treatment. ... ...
